TGTX icon

TG Therapeutics

235 hedge funds and large institutions have $762M invested in TG Therapeutics in 2023 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 100 increasing their positions, 51 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

4% less funds holding

Funds holding: 244235 (-9)

13% less first-time investments, than exits

New positions opened: 47 | Existing positions closed: 54

65% less capital invested

Capital invested by funds: $2.19B → $762M (-$1.43B)

Holders
235
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$25.3M
Puts
$24M
Net Calls
Net Calls Change

Top Sellers

1 -$230M
2 -$43.1M
3 -$40.4M
4
Alkeon Capital Management
Alkeon Capital Management
New York
-$38.4M
5
Man Group
Man Group
United Kingdom
-$17.1M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$993K
77
$970K
78
$836K
79
$826K
80
$816K
81
$792K
82
$791K
83
$782K
84
$766K
85
$764K
86
$761K
87
$754K
88
$745K
89
$715K
90
$674K
91
$660K
92
$657K
93
$652K
94
$631K
95
$605K
96
$597K
97
$597K
98
$594K
99
$573K
100
$562K